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The Pandora study is a General Practitioners' (GPs)
project, whose aim is to establish an epidemiological da-
tabase in order to describe and follow up hypertensive
patients in the Ravenna area.
OBJECTIVE: To investigate the feasibility of a cost of ill-
ness of the hypertensive patient in terms of health care re-
source use, and to produce an average cost per patient.
METHODS: Retrospective cost-of-illness analysis based
on records of 209 hypertensive patients followed by five
GPs. This preliminary analysis has been performed in the
perspective of the community (including both direct and
indirect costs). Patients analyzed were enrolled between
April and November 1996 and followed up at least for 6
months. Hospital admissions, GP, specialist, and emer-
gency room visits, instrumental and laboratory tests,
drugs, and productivity losses due to visits and hospital-
izations were analyzed; each cost variable was valued in
Italian Liras 1996 (1,548 Lit = 1 US$) using published
regional or national tariffs and market prices for drugs.
RESULTS: The average cost per patient per 6 months
was Lit 732,404. Direct costs accounted for 77.6% of the
total value, while the remaining 22.4% was due to indi-
rect costs (i.e., productivity losses). The major cost driver
was drugs (35.1 %) (26% was the share of antihyperten-
sive drugs), followed by visits (21.4%), hospitalizations
(16.0%), and tests (5.1 %).
CONCLUSION: Collection of cost data at the General
Practitioner's level is very effective as it allows a precise
and appropriate analysis; only a few studies document
the cost of the hypertensive patient and none has been
done in Italy: our study creates the foundation for further
in-depth analysis.
